CDT Competitors & Alternatives

Compare CDT Equity Inc. with similar stocks in the same industry

Biotechnology

CDT

Main Stock
$0.23
-13.89%
Tradestie Score
29
Market Cap
$2.12M

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other Drug Design
Competitive Moat: None
Core Technology Stack: Small molecule immunomodulators
Major Customers 3
Specialty pharmacies Clinical research organizations Hospital systems
Critical Suppliers 2
API manufacturers Contract research organizations
Direct Ecosystem Rivals 2

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
ATPC Agape ATP Corporation Common Stock
$1.16
-15.94%
$60.51M - 48 Compare
SPRC SciSparc Ltd. Ordinary Shares
$0.20
-34.83%
$9.78M 0.0 45 Compare
VCIG VCI Global Limited Ordinary Share
$2.66
-13.07%
$9.08M - 35 Compare
NIVF NewGenIvf Group Limited Class A ordinary shares
$0.03
-23.14%
$4.04M - 47 Compare
NXTS NXTS
$1.58
-7.06%
- - 26 Compare
XBI SPDR S&P Biotech ETF
$140.18
-2.73%
- - 52 Compare
IBB iShares Biotechnology ETF
$199.54
-2.05%
- - 44 Compare

Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry